Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> JOHNSON & JOHNSON Latest News

1 HOUR AGO - Huffington Post

A Must Read - Share

Johnson & Johnson Pulls Controversial Device That May Spread Cancer

(Reuters) - Johnson & Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids. J&J's Ethicon unit in April suspended sales and distribution of the devices while their role in treating symptomatic fibroid disease is reviewed by the ...

Tags: Johnson & Johnson Pulls Controversial Device That May Spread Cancer,  Johnson & Johnson Latest News

2 HOURS AGO - TheStreet

A Must Read - Share

Why Johnson & Johnson (JNJ) Stock Is Lower Today

NEW YORK (TheStreet) -- Shares of Johnson & Johnson are down -0.66% to $101.62 in pre-market trade after the health care products company last night said it was withdrawing a surgical tool that can spread cancer in women, effectively removing the device's largest manufacturer from the market amid a contentious debate over its use, the Wall Street Journal reports. The company ...

Tags: Why Johnson & Johnson (JNJ) Stock Is Lower Today,  Johnson & Johnson Latest News

5 HOURS AGO - NPR

A Must Read - Share

Senate Antitrust Panel Eyes Contact Lens Pricing Policies

Under "UPP," or universal pricing policies, manufacturers like Johnson & Johnson tell retailers they can't sell their contact lens below a certain price. And if they do, their supply will be cut off.

Tags: Senate Antitrust Panel Eyes Contact Lens Pricing Policies,  Johnson & Johnson Latest News

16 HOURS AGO - Washington Business Journal

A Must Read - Share

Dendreon appoints retired Johnson & Johnson exec as new CEO

Seattle cancer drug-maker Dendreon has named 71-year-old retired biotech executive W. Thomas Amick as the company's new CEO. Amick will take over from former president and CEO John Johnson, who announced his resignation in June. The announcement comes as Dendreon has struggled to find a place in the market for its expensive prostate cancer drug, Provenge. The publicly traded company ...

Tags: Dendreon appoints retired Johnson & Johnson exec as new CEO,  Johnson & Johnson Latest News

JUL 28, 2014 - TheStreet

A Must Read - Share

What Makes Johnson & Johnson a Healthy Dividend Investment

NEW YORK (TheStreet) -- Ever since its inception in 1886, Johnson & Johnson has managed to grow significantly and has been a lucrative company worthy of your investment. Despite the fact that its stock, at $102, is slightly overpriced, it is an excellent investment for risk-averse investors owing to a number of contributing factors. Shares are up nearly 12% for ...

Tags: What Makes Johnson & Johnson a Healthy Dividend Investment,  Johnson & Johnson Latest News